#Vaccines

The NIH has said it will pour nearly $200 million into developing cancer vaccines starting in December.

Health secretary’s effort to alter makeup of ACIP panel means no new recommendations coming – even as new vaccines are approved

An apparent leak prompted Merck and Moderna to release the full trial results ahead of schedule, but investors puzzlingly greeted the good news by sending the companies’ stock prices down.

Police seize doses of hepatitis B vaccine from people at center of dispute over research on African newborns

Guinea-Bissau police said hepatitis B vaccine doses were taken as part of an investigation.

Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC) The COVAX Facility, and the AMC within it, is designed to guarantee rapid,…

COVAX is a global initiative aimed at working with vaccine manufacturers to provide countries worldwide equitable access to safe and effective vaccines, once they are licensed and approved.

pEVAC-PS is the first experimental vaccine designed completely with AI to be tested in a human trial.

President Donald Trump is giving his endorsement to a January study by the Department of Health and Human Services that calls for cutting the number of vaccines recommended for every American child

From Ars Technica: Routine vaccines may cut dementia risk—experts have startling hypothesis on how

A clade I mpox case has been confirmed in Connecticut, marking the first identified case in the state. Officials say it does not pose a risk to the general public.

From Independent RSS Feed: The White House told RFK Jr to tone down his statements questioning vaccines. That hasn’t stopped him behind the scenes

Kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA commissioner

From claims of an Israeli false flag to efforts to sell ivermectin, influencers and grifters are using lessons learned from Covid-19 to push their baseless conspiracy theories.

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.

Confidence in vaccine effectiveness is slipping, in part because the stories that once served to build public trust are no longer being heard.

From Salon.com: “Much smaller shots”: Trump thinks vaccines are too “big” for babies

From The Guardian: ‘The FDA is a complete mess’: Trump makes fate of agency chief unclear as public trust plummits

The misinformation resurged even as the World Health Organization insisted there was minimal risk to the general public from passengers of the MV Hondius.